Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Apr;71(4):950–959. doi: 10.1172/JCI110849

Receptor-mediated Catabolism of Low Density Lipoprotein in Man. QUANTITATION USING GLUCOSYLATED LOW DENSITY LIPOPROTEIN

Y Antero Kesaniemi 1, Joseph L Witztum 1, Urs P Steinbrecher 1
PMCID: PMC436952  PMID: 6300194

Abstract

Low density lipoprotein (LDL) catabolism occurs by LDL receptor-dependent and LDL receptor-independent pathways. We have shown previously that nonenzymatic glucosylation of LDL in the presence of cyanoborohydride irreversibly blocks the lysine residues of LDL. Glucosylated LDL (GLC-LDL) was not degraded by the LDL receptor of fibroblasts, and its degradation by macrophages was similar to that of native LDL. This suggested that GLC-LDL should be a good tracer of LDL receptor-independent catabolism, and if combined with a tracer of total LDL catabolism, should enable one to calculate the extent of LDL receptor-dependent catabolism.

To determine the contribution of each pathway in man, we prepared 125I-GLC-LDL and 131I-control LDL and simultaneously determined the fractional catabolic rate (FCR) of each tracer in four subjects. In preliminary experiments, we showed that the conditions for glucosylation did not affect LDL turnover. In the four subjects, the FCR for total LDL catabolism ranged from 0.345 to 0.724 d-1 with a mean of 0.57±0.16 d-1. The FCR of GLC-LDL varied from 0.071 to 0.141 d-1 with a mean of 0.11±0.03 d-1. The latter is similar to the FCR reported for native LDL in subjects with homozygous familial hypercholesterolemia, supporting the interpretation that GLC-LDL traces only the receptor-independent pathway. Despite the wide range of total LDL catabolism in these subjects. LDL receptor-independent catabolism accounted for only 19.5-20.6% of total catabolism. In turn, LDL receptor-dependent catabolism accounted for 80% of total clearance in each person. Furthermore, while the decay curve of LDL showed the usual biphasic pattern, the decay curve of GLC-LDL was monoexponential in each subject even when followed for as long as 48 d. This suggests that LDL receptor activity is responsible for the biphasic nature of LDL decay.

These studies emphasize the central role of LDL receptor activity in normal LDL metabolism in man.

Full text

PDF
950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Attie A. D., Pittman R. C., Steinberg D. Hepatic catabolism of low density lipoprotein: mechanisms and metabolic consequences. Hepatology. 1982 Mar-Apr;2(2):269–281. doi: 10.1002/hep.1840020215. [DOI] [PubMed] [Google Scholar]
  2. Bilheimer D. W., Goldstein J. L., Grundy S. M., Brown M. S. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest. 1975 Dec;56(6):1420–1430. doi: 10.1172/JCI108223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bilheimer D. W., Stone N. J., Grundy S. M. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. J Clin Invest. 1979 Aug;64(2):524–533. doi: 10.1172/JCI109490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bilheimer D. W., Watanabe Y., Kita T. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1982 May;79(10):3305–3309. doi: 10.1073/pnas.79.10.3305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown M. S., Kovanen P. T., Goldstein J. L. Regulation of plasma cholesterol by lipoprotein receptors. Science. 1981 May 8;212(4495):628–635. doi: 10.1126/science.6261329. [DOI] [PubMed] [Google Scholar]
  6. Drevon C. A., Attie A. D., Pangburn S. H., Steinberg D. Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts. J Lipid Res. 1981 Jan;22(1):37–46. [PubMed] [Google Scholar]
  7. Goldstein J. L., Brown M. S. Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism. 1977 Nov;26(11):1257–1275. doi: 10.1016/0026-0495(77)90119-6. [DOI] [PubMed] [Google Scholar]
  8. Grundy S. M. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J Clin Invest. 1975 Feb;55(2):269–282. doi: 10.1172/JCI107930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kesaniemi Y. A., Grundy S. M. Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man. J Clin Invest. 1982 Jul;70(1):13–22. doi: 10.1172/JCI110585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kita T., Brown M. S., Watanabe Y., Goldstein J. L. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2268–2272. doi: 10.1073/pnas.78.4.2268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Langer T., Strober W., Levy R. I. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest. 1972 Jun;51(6):1528–1536. doi: 10.1172/JCI106949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lindgren F. T., Jensen L. C., Wills R. D., Freeman N. K. Flotation rates, molecular weights and hydrated densities of the low-density lipoproteins. Lipids. 1969 Sep;4(5):337–344. doi: 10.1007/BF02531003. [DOI] [PubMed] [Google Scholar]
  14. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  15. Mahley R. W., Weisgraber K. H., Melchior G. W., Innerarity T. L., Holcombe K. S. Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. Proc Natl Acad Sci U S A. 1980 Jan;77(1):225–229. doi: 10.1073/pnas.77.1.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pittman R. C., Carew T. E., Attie A. D., Witztum J. L., Watanabe Y., Steinberg D. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem. 1982 Jul 25;257(14):7994–8000. [PubMed] [Google Scholar]
  17. STEINFELD J. L., PATON R. R., FLICK A. L., MILCH R. A., BEACH F. E., TABERN D. L. Distribution and degradation of human serum albumin labeled with I 131 by different techniques. Ann N Y Acad Sci. 1957 Aug 30;70(1):109–121. doi: 10.1111/j.1749-6632.1957.tb35382.x. [DOI] [PubMed] [Google Scholar]
  18. Shepherd J., Bicker S., Lorimer A. R., Packard C. J. Receptor-mediated low density lipoprotein catabolism in man. J Lipid Res. 1979 Nov;20(8):999–1006. [PubMed] [Google Scholar]
  19. Simons L. A., Reichl D., Myant N. B., Mancini M. The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form. Atherosclerosis. 1975 Mar-Apr;21(2):283–298. doi: 10.1016/0021-9150(75)90087-8. [DOI] [PubMed] [Google Scholar]
  20. Slater H. R., Packard C. J., Shepherd J. Measurement of receptor-independent lipoprotein catabolism using 1,2 cyclohexanedione-modified low density lipoprotein. J Lipid Res. 1982 Jan;23(1):92–96. [PubMed] [Google Scholar]
  21. Soutar A. K., Myant N. B., Thompson G. R. Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis. 1977 Nov;28(3):247–256. doi: 10.1016/0021-9150(77)90174-5. [DOI] [PubMed] [Google Scholar]
  22. Steinbrecher U. P., Witztum J. L., Kesaniemi Y. A., Elam R. L. Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism. J Clin Invest. 1983 Apr;71(4):960–964. doi: 10.1172/JCI110850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tanzawa K., Shimada Y., Kuroda M., Tsujita Y., Arai M., Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 1980 Aug 25;118(1):81–84. doi: 10.1016/0014-5793(80)81223-3. [DOI] [PubMed] [Google Scholar]
  24. Thompson G. R., Soutar A. K., Spengel F. A., Jadhav A., Gavigan S. J., Myant N. B. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2591–2595. doi: 10.1073/pnas.78.4.2591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Turner J. D., Le N. A., Brown W. V. Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. Am J Physiol. 1981 Jul;241(1):E57–E63. doi: 10.1152/ajpendo.1981.241.1.E57. [DOI] [PubMed] [Google Scholar]
  26. Weisgraber K. H., Innerarity T. L., Mahley R. W. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem. 1978 Dec 25;253(24):9053–9062. [PubMed] [Google Scholar]
  27. Witztum J. L., Mahoney E. M., Branks M. J., Fisher M., Elam R., Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982 Apr;31(4 Pt 1):283–291. doi: 10.2337/diab.31.4.283. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES